Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Burghardt

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Acta Crystallographica. Section E, Crystallographic Communications|August 7, 2024
Rerefinement of the crystal structure of BiF<sub>5</sub>Tobias Burghardt Wassermann, Florian Kraus
Pharmaceutics|June 27, 2024
Dual Effect by Chemical Electron Transfer Enhanced siRNA Lipid Nanoparticles: Reactive Oxygen Species-Triggered Tumor Cell Killing Aggravated by Nrf2 Gene SilencingFengrong Zhang, Tobias Burghardt, Miriam Höhn, et al.
International Journal of Molecular Sciences|May 14, 2025
CRISPR/Cas9 Ribonucleoprotein Delivery Enhanced by Lipo-Xenopeptide Carriers and Homology-Directed Repair Modulators: Insights from Reporter Cell LinesXianjin Luo, Eric Weidinger, Tobias Burghardt, et al.
Bioconjugate Chemistry|March 26, 2025
Evolution of Lipo-Xenopeptide Carriers for siRNA Delivery: Interplay of Stabilizing SubunitsMina Yazdi, Tobias Burghardt, Johanna Seidl, et al.
Theranostics|June 8, 2022
Aptamers used for molecular imaging and theranostics - recent developmentsLennart Bohrmann, Tobias Burghardt, Charles Haynes, et al.
Journal of the American Chemical Society|July 3, 2023
Chemical Evolution of Amphiphilic Xenopeptides for Potentiated Cas9 Ribonucleoprotein DeliveryYi Lin, Xianjin Luo, Tobias Burghardt, et al.
ACS Omega|April 3, 2023
Quantitative Evaluation of a Multimodal Aptamer-Targeted Long-Circulating Polymer for Tumor TargetingLennart Bohrmann, Tobias Burghardt, Cristina Rodríguez-Rodríguez, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 8, 2024
Dual pH-responsive CRISPR/Cas9 ribonucleoprotein xenopeptide complexes for genome editingXianjin Luo, Janin Germer, Tobias Burghardt, et al.
Bioconjugate Chemistry|May 25, 2026
Enhanced Intramuscular mRNA Activity of Peptide-Lipid Nanoparticles with Hydrophobized Head GroupsEric Weidinger, Tobias Burghardt, Lennart Obeser, et al.
Advanced Materials (Deerfield Beach, Fla.)|March 31, 2023
Molecular Chameleon Carriers for Nucleic Acid Delivery: The Sweet Spot between Lipoplexes and PolyplexesSophie Thalmayr, Melina Grau, Lun Peng, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Acta Crystallographica. Section E, Crystallographic Communications|August 7, 2024
Rerefinement of the crystal structure of BiF<sub>5</sub>Tobias Burghardt Wassermann, Florian Kraus
Pharmaceutics|June 27, 2024
Dual Effect by Chemical Electron Transfer Enhanced siRNA Lipid Nanoparticles: Reactive Oxygen Species-Triggered Tumor Cell Killing Aggravated by Nrf2 Gene SilencingFengrong Zhang, Tobias Burghardt, Miriam Höhn, et al.
International Journal of Molecular Sciences|May 14, 2025
CRISPR/Cas9 Ribonucleoprotein Delivery Enhanced by Lipo-Xenopeptide Carriers and Homology-Directed Repair Modulators: Insights from Reporter Cell LinesXianjin Luo, Eric Weidinger, Tobias Burghardt, et al.
Bioconjugate Chemistry|March 26, 2025
Evolution of Lipo-Xenopeptide Carriers for siRNA Delivery: Interplay of Stabilizing SubunitsMina Yazdi, Tobias Burghardt, Johanna Seidl, et al.
Theranostics|June 8, 2022
Aptamers used for molecular imaging and theranostics - recent developmentsLennart Bohrmann, Tobias Burghardt, Charles Haynes, et al.
Journal of the American Chemical Society|July 3, 2023
Chemical Evolution of Amphiphilic Xenopeptides for Potentiated Cas9 Ribonucleoprotein DeliveryYi Lin, Xianjin Luo, Tobias Burghardt, et al.
ACS Omega|April 3, 2023
Quantitative Evaluation of a Multimodal Aptamer-Targeted Long-Circulating Polymer for Tumor TargetingLennart Bohrmann, Tobias Burghardt, Cristina Rodríguez-Rodríguez, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 8, 2024
Dual pH-responsive CRISPR/Cas9 ribonucleoprotein xenopeptide complexes for genome editingXianjin Luo, Janin Germer, Tobias Burghardt, et al.
Bioconjugate Chemistry|May 25, 2026
Enhanced Intramuscular mRNA Activity of Peptide-Lipid Nanoparticles with Hydrophobized Head GroupsEric Weidinger, Tobias Burghardt, Lennart Obeser, et al.
Advanced Materials (Deerfield Beach, Fla.)|March 31, 2023
Molecular Chameleon Carriers for Nucleic Acid Delivery: The Sweet Spot between Lipoplexes and PolyplexesSophie Thalmayr, Melina Grau, Lun Peng, et al.
Pageof 2